Graphene as cancer theranostic tool: Progress and future challenges

Theranostics

Volumn 5, Issue 7, 2015, Pages 710-723

  Orecchioni, Marco ^a   Cabizza, Roberto ^a   Bianco, Alberto ^b   Delogu, Lucia Gemma ^a  

^a UNIVERSITY OF SASSARI   (Italy)

^b CNRS   (France)

Author keywords

Cancer; Carbon materials; Graphene; Nanomedicine; Theranostics; Therapy; Tumor

Indexed keywords

ALGINIC ACID; ANASTROZOLE; BETA LAPACHONE; CAMPTOTHECIN; CHITOSAN; CISPLATIN; CURCUMIN; DOXORUBICIN; ELLAGIC ACID; EPIRUBICIN; FLUOROURACIL; FOLIC ACID; GRAPHENE; GRAPHENE OXIDE; HYPOCRELLIN A; MACROGOL; MALTODEXTRIN; NANOCRYSTAL; NANOMATERIAL; OXALIPLATIN; PACLITAXEL; POLOXAMER; POLYSORBATE 80; QUANTUM DOT; REDUCED GRAPHENE; RITUXIMAB; SMALL INTERFERING RNA; TALAPORFIN; TAMOXIFEN CITRATE; UNCLASSIFIED DRUG; UNINDEXED DRUG; ANTINEOPLASTIC AGENT; DRUG CARRIER; GRAPHITE;

BIOMEDICINE; BRAIN CANCER; BREAST CANCER; CANCER DIAGNOSIS; CANCER THERANOSTICS; CANCER THERAPY; CAUSE OF DEATH; COLON CANCER; DIAGNOSTIC ACCURACY; DRUG DELIVERY SYSTEM; EARLY DIAGNOSIS; ECHOGRAPHY; FLUORESCENCE IMAGING; GENE TARGETING; HUMAN; IMAGING; LIVER CELL CARCINOMA; NANOTECHNOLOGY; NEOPLASM; NONHUMAN; PHOTODYNAMIC THERAPY; PHOTOTHERMAL THERAPY; REVIEW; SKIN CANCER; THERAPY; UTERINE CERVIX CANCER; ANIMAL; CHEMISTRY; GENE THERAPY; NEOPLASMS; PHOTOCHEMOTHERAPY; PROCEDURES;

ANIMALS; ANTINEOPLASTIC AGENTS; DRUG CARRIERS; GENETIC THERAPY; GRAPHITE; HUMANS; NEOPLASMS; PHOTOCHEMOTHERAPY;

EID: 84938723755     PISSN: None     EISSN: 18387640     Source Type: Journal    
DOI: 10.7150/thno.11387     Document Type: Review

References (134)

1. Lopez-Gomez M, Malmierca E, de Gorgolas M, Casado E. Cancer in developing countries: the next most preventable pandemic. The global problem of cancer. Critical reviews in oncology/hematology. 2013; 88: 117-22. doi:10.1016/j.critrevonc.2013.03.011.
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA: a cancer journal for clinicians. 2011; 61: 69-90. doi:10.3322/caac.20107.
3. Madeddu R, Solinas G, Forte G, Bocca B, Asara Y, Tolu P, et al. Diet and nutrients are contributing factors that influence blood cadmium levels. Nutrition research. 2011; 31: 691-7. doi:10.1016/j.nutres.2011.09.003.
4. Fernandez-Fernandez A, Manchanda R, McGoron AJ. Theranostic applications of nanomaterials in cancer: drug delivery, image-guided therapy, and multifunctional platforms. Applied biochemistry and biotechnology. 2011; 165: 1628-51. doi:10.1007/s12010-011-9383-z.
5. Shanmugam V, Selvakumar S, Yeh CS. Near-infrared light-responsive nanomaterials in cancer therapeutics. Chemical Society reviews. 2014; 43: 6254-87. doi:10.1039/c4cs00011k.
6. Sechi G, Bedognetti D, Sgarrella F, Van Eperen L, Marincola FM, Bianco A, et al. The perception of nanotechnology and nanomedicine: a worldwide social media study. Nanomedicine. 2014; 9: 1475-86. doi:10.2217/nnm.14.78.
7. Orecchioni M, Bedognetti D, Sgarrella F, Marincola FM, Bianco A, Delogu LG. Impact of carbon nanotubes and graphene on immune cells. Journal of translational medicine. 2014; 12: 138. doi:10.1186/1479-5876-12-138.
8. Servant A, Bianco A, Prato M, Kostarelos K. Graphene for multi-functional synthetic biology: the last 'zeitgeist' in nanomedicine. Bioorganic & medicinal chemistry letters. 2014; 24: 1638-49. doi:10.1016/j.bmcl.2014.01.051.
9. Shen H, Zhang L, Liu M, Zhang Z. Biomedical applications of graphene. Theranostics. 2012; 2: 283-94. doi:10.7150/thno.3642.
10. Geim AK, Novoselov KS. The rise of graphene. Nature materials. 2007; 6: 183-91. doi:10.1038/nmat1849.
11. Geim AK. Graphene: status and prospects. Science. 2009; 324: 1530-4. doi:10.1126/science.1158877.
12. Palermo V. Not a molecule, not a polymer, not a substrate. the many faces of graphene as a chemical platform. Chemical communications. 2013; 49: 2848-57. doi:10.1039/c3cc37474b.
13. Gao W, Alemany LB, Ci L, Ajayan PM. New insights into the structure and reduction of graphite oxide. Nature chemistry. 2009; 1: 403-8. doi:10.1038/nchem.281.
14. Bianco A, Cheng HM, Enoki T, Gogotsi Y, Hurt RH, Koratkar N, et al. All in the graphene family - A recommended nomenclature for two-dimensional carbon materials. Carbon. 2013; 65: 1-6. doi:Doi 10.1016/J. Carbon.2013.08.038.
15. Zhang L, Xia J, Zhao Q, Liu L, Zhang Z. Functional graphene oxide as a nanocarrier for controlled loading and targeted delivery of mixed anticancer drugs. Small. 2010; 6: 537-44. doi:10.1002/smll.200901680.
16. Feng L, Zhang S, Liu Z. Graphene based gene transfection. Nanoscale. 2011; 3: 1252-7. doi:10.1039/c0nr00680g.
17. Dinescu S, Ionita M, Pandele AM, Galateanu B, Iovu H, Ardelean A, et al. In vitro cytocompatibility evaluation of chitosan/graphene oxide 3D scaffold composites designed for bone tissue engineering. Bio-medical materials and engineering. 2014; 24: 2249-56. doi:10.3233/BME-141037.
18. Cveticanin J, Joksic G, Leskovac A, Petrovic S, Sobot AV, Neskovic O. Using carbon nanotubes to induce micronuclei and double strand breaks of the DNA in human cells. Nanotechnology. 2010; 21: 015102. doi:10.1088/0957-4484/21/1/015102.
19. Russier J, Treossi E, Scarsi A, Perrozzi F, Dumortier H, Ottaviano L, et al. Evidencing the mask effect of graphene oxide: a comparative study on primary human and murine phagocytic cells. Nanoscale. 2013; 5: 11234-47. doi:10.1039/c3nr03543c.
20. Jaworski S, Sawosz E, Grodzik M, Winnicka A, Prasek M, Wierzbicki M, et al. In vitro evaluation of the effects of graphene platelets on glioblastoma multiforme cells. International journal of nanomedicine. 2013; 8: 413-20. doi:10.2147/IJN.S39456.
21. Gurunathan S, Han J, Park JH, Kim JH. An in vitro evaluation of graphene oxide reduced by Ganoderma spp. in human breast cancer cells (MDA-MB-231). International journal of nanomedicine. 2014; 9: 1783-97. doi:10.2147/IJN.S57735.
22. Zhou H, Zhang B, Zheng J, Yu M, Zhou T, Zhao K, et al. The inhibition of migration and invasion of cancer cells by graphene via the impairment of mitochondrial respiration. Biomaterials. 2014; 35: 1597-607. doi:10.1016/j.biomaterials.2013.11.020.
23. Yang K, Feng L, Shi X, Liu Z. Nano-graphene in biomedicine: theranostic applications. Chemical Society reviews. 2013; 42: 530-47. doi:10.1039/c2cs35342c.
24. Rastogi V, Yadav P, Bhattacharya SS, Mishra AK, Verma N, Verma A, et al. Carbon nanotubes: an emerging drug carrier for targeting cancer cells. Journal of drug delivery. 2014; 2014: 670815. doi:10.1155/2014/670815.
25. Delogu LG, Magrini A, Bergamaschi A, Rosato N, Dawson MI, Bottini N, et al. Conjugation of antisense oligonucleotides to PEGylated carbon nanotubes enables efficient knockdown of PTPN22 in T lymphocytes. Bioconjugate chemistry. 2009; 20: 427-31. doi:10.1021/bc800540j.
26. Delogu LG, Stanford SM, Santelli E, Magrini A, Bergamaschi A, Motamedchaboki K, et al. Carbon nanotube-based nanocarriers: the importance of keeping it clean. Journal of nanoscience and nanotechnology. 2010; 10: 5293-301.
27. Feng L, Liu Z. Graphene in biomedicine: opportunities and challenges. Nanomedicine. 2011; 6: 317-24. doi:10.2217/nnm.10.158.
28. Yang K, Zhang S, Zhang G, Sun X, Lee ST, Liu Z. Graphene in mice: ultrahigh in vivo tumor uptake and efficient photothermal therapy. Nano letters. 2010; 10: 3318-23. doi:10.1021/nl100996u.
29. Delogu LG, Vidili G, Venturelli E, Menard-Moyon C, Zoroddu MA, Pilo G, et al. Functionalized multiwalled carbon nanotubes as ultrasound contrast agents. Proceedings of the National Academy of Sciences of the United States of America. 2012; 109: 16612-7. doi:10.1073/pnas.1208312109.
30. Zhang H, Yee D, Wang C. Quantum dots for cancer diagnosis and therapy: biological and clinical perspectives. Nanomedicine. 2008; 3: 83-91. doi:10.2217/17435889.3.1.83.
31. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. International journal of cancer Journal international du cancer. 2015; 136: E359-E86. doi:10.1002/ijc.29210.
32. Sahoo NG, Bao H, Pan Y, Pal M, Kakran M, Cheng HK, et al. Functionalized carbon nanomaterials as nanocarriers for loading and delivery of a poorly water-soluble anticancer drug: a comparative study. Chemical communications. 2011; 47: 5235-7. doi:10.1039/c1cc00075f.
33. Sun X, Liu Z, Welsher K, Robinson JT, Goodwin A, Zaric S, et al. Nano-Graphene Oxide for Cellular Imaging and Drug Delivery. Nano research. 2008; 1: 203-12. doi:10.1007/s12274-008-8021-8.
34. Kakran M, Sahoo NG, Bao H, Pan Y, Li L. Functionalized graphene oxide as nanocarrier for loading and delivery of ellagic Acid. Current medicinal chemistry. 2011; 18: 4503-12.
35. Kim H, Namgung R, Singha K, Oh IK, Kim WJ. Graphene oxide-polyethylenimine nanoconstruct as a gene delivery vector and bioimaging tool. Bioconjugate chemistry. 2011; 22: 2558-67. doi:10.1021/bc200397j.
36. Zhang W, Guo Z, Huang D, Liu Z, Guo X, Zhong H. Synergistic effect of chemo-photothermal therapy using PEGylated graphene oxide. Biomaterials. 2011; 32: 8555-61. doi:10.1016/j.biomaterials.2011.07.071.
37. Tian B, Wang C, Zhang S, Feng L, Liu Z. Photothermally enhanced photodynamic therapy delivered by nano-graphene oxide. ACS nano. 2011; 5: 7000-9. doi:10.1021/nn201560b.
38. Lu YJ, Yang HW, Hung SC, Huang CY, Li SM, Ma CC, et al. Improving thermal stability and efficacy of BCNU in treating glioma cells using PAA-functionalized graphene oxide. International journal of nanomedicine. 2012; 7: 1737-47. doi:10.2147/IJN.S29376.
39. Hu H, Yu J, Li Y, Zhao J, Dong H. Engineering of a novel pluronic F127/graphene nanohybrid for pH responsive drug delivery. Journal of biomedical materials research Part A. 2012; 100: 141-8. doi:10.1002/jbm.a.33252.
40. Wu J, Wang YS, Yang XY, Liu YY, Yang JR, Yang R, et al. Graphene oxide used as a carrier for adriamycin can reverse drug resistance in breast cancer cells. Nanotechnology. 2012; 23: 355101. doi:10.1088/0957-4484/23/35/355101.
41. Zheng XT, Li CM. Restoring basal planes of graphene oxides for highly efficient loading and delivery of beta-lapachone. Molecular pharmaceutics. 2012; 9: 615-21. doi:10.1021/mp2005356.
42. Yang Y, Zhang YM, Chen Y, Zhao D, Chen JT, Liu Y. Construction of a graphene oxide based noncovalent multiple nanosupramolecular assembly as a scaffold for drug delivery. Chemistry. 2012; 18: 4208-15. doi:10.1002/chem.201103445.
43. Misra SK, Kondaiah P, Bhattacharya S, Rao CN. Graphene as a nanocarrier for tamoxifen induces apoptosis in transformed cancer cell lines of different origins. Small. 2012; 8: 131-43. doi:10.1002/smll.201101640.
44. Wei G, Yan M, Dong R, Wang D, Zhou X, Chen J, et al. Covalent modification of reduced graphene oxide by means of diazonium chemistry and use as a drug-delivery system. Chemistry. 2012; 18: 14708-16. doi:10.1002/chem.201200843.
45. Hong H, Yang K, Zhang Y, Engle JW, Feng L, Yang Y, et al. In vivo targeting and imaging of tumor vasculature with radiolabeled, antibody-conjugated nanographene. ACS nano. 2012; 6: 2361-70. doi:10.1021/nn204625e.
46. Kavitha T, Abdi SI, Park SY. pH-sensitive nanocargo based on smart polymer functionalized graphene oxide for site-specific drug delivery. Physical chemistry chemical physics: PCCP. 2013; 15: 5176-85. doi:10.1039/c3cp00008g.
47. Liu G, Shen H, Mao J, Zhang L, Jiang Z, Sun T, et al. Transferrin modified graphene oxide for glioma-targeted drug delivery: in vitro and in vivo evaluations. ACS applied materials & interfaces. 2013; 5: 6909-14. doi:10.1021/am402128s.
48. Yang HW, Hua MY, Hwang TL, Lin KJ, Huang CY, Tsai RY, et al. Non-invasive synergistic treatment of brain tumors by targeted chemotherapeutic delivery and amplified focused ultrasound-hyperthermia using magnetic nanographene oxide. Advanced materials. 2013; 25: 3605-11. doi:10.1002/adma.201301046.
49. Jin R, Ji X, Yang Y, Wang H, Cao A. Self-assembled graphene-dextran nanohybrid for killing drug-resistant cancer cells. ACS applied materials & interfaces. 2013; 5: 7181-9. doi:10.1021/am401523y.
50. Wang C, Wu C, Zhou X, Han T, Xin X, Wu J, et al. Enhancing cell nucleus accumulation and DNA cleavage activity of anti-cancer drug via graphene quantum dots. Scientific reports. 2013; 3: 2852. doi:10.1038/srep02852.
51. Zhi F, Dong H, Jia X, Guo W, Lu H, Yang Y, et al. Functionalized graphene oxide mediated adriamycin delivery and miR-21 gene silencing to overcome tumor multidrug resistance in vitro. PloS one. 2013; 8: e60034. doi:10.1371/journal.pone.0060034.
52. Kim H, Lee D, Kim J, Kim TI, Kim WJ. Photothermally triggered cytosolic drug delivery via endosome disruption using a functionalized reduced graphene oxide. ACS nano. 2013; 7: 6735-46. doi:10.1021/nn403096s.
53. Liu CW, Xiong F, Jia HZ, Wang XL, Cheng H, Sun YH, et al. Graphene-based anticancer nanosystem and its biosafety evaluation using a zebrafish model. Biomacromolecules. 2013; 14: 358-66. doi:10.1021/bm3015297.
54. Miao W, Shim G, Kang CM, Lee S, Choe YS, Choi HG, et al. Cholesteryl hyaluronic acid-coated, reduced graphene oxide nanosheets for anti-cancer drug delivery. Biomaterials. 2013; 34: 9638-47. doi:10.1016/j.biomaterials.2013.08.058.
55. Fan X, Jiao G, Zhao W, Jin P, Li X. Magnetic Fe3O4-graphene composites as targeted drug nanocarriers for pH-activated release. Nanoscale. 2013; 5: 1143-52. doi:10.1039/c2nr33158f.
56. Arya N, Arora A, Vasu KS, Sood AK, Katti DS. Combination of single walled carbon nanotubes/graphene oxide with paclitaxel: a reactive oxygen species mediated synergism for treatment of lung cancer. Nanoscale. 2013; 5: 2818-29. doi:10.1039/c3nr33190c.
57. Yin D, Li Y, Lin H, Guo B, Du Y, Li X, et al. Functional graphene oxide as a plasmid-based Stat3 siRNA carrier inhibits mouse malignant melanoma growth in vivo. Nanotechnology. 2013; 24: 105102. doi:10.1088/0957-4484/24/10/105102.
58. Shi S, Yang K, Hong H, Valdovinos HF, Nayak TR, Zhang Y, et al. Tumor vasculature targeting and imaging in living mice with reduced graphene oxide. Biomaterials. 2013; 34: 3002-9. doi:10.1016/j.biomaterials.2013.01.047.
59. Chen ML, He YJ, Chen XW, Wang JH. Quantum-dot-conjugated graphene as a probe for simultaneous cancer-targeted fluorescent imaging, tracking, and monitoring drug delivery. Bioconjugate chemistry. 2013; 24: 387-97. doi:10.1021/bc3004809.
60. Miao W, Shim G, Lee S, Lee S, Choe YS, Oh YK. Safety and tumor tissue accumulation of pegylated graphene oxide nanosheets for co-delivery of anticancer drug and photosensitizer. Biomaterials. 2013; 34: 3402-10. doi:10.1016/j.biomaterials.2013.01.010.
61. Wang Y, Wang K, Zhao J, Liu X, Bu J, Yan X, et al. Multifunctional mesoporous silica-coated graphene nanosheet used for chemo-photothermal synergistic targeted therapy of glioma. Journal of the American Chemical Society. 2013; 135: 4799-804. doi:10.1021/ja312221g.
62. Yang HW, Lu YJ, Lin KJ, Hsu SC, Huang CY, She SH, et al. EGRF conjugated PEGylated nanographene oxide for targeted chemotherapy and photothermal therapy. Biomaterials. 2013; 34: 7204-14. doi:10.1016/j.biomaterials.2013.06.007.
63. Qin XC, Guo ZY, Liu ZM, Zhang W, Wan MM, Yang BW. Folic acid-conjugated graphene oxide for cancer targeted chemo-photothermal therapy. Journal of photochemistry and photobiology B, Biology. 2013; 120: 156-62. doi:10.1016/j.jphotobiol.2012.12.005.
64. Wang C, Mallela J, Garapati US, Ravi S, Chinnasamy V, Girard Y, et al. A chitosan-modified graphene nanogel for noninvasive controlled drug release. Nanomedicine. 2013; 9: 903-11. doi:10.1016/j.nano.2013.01.003.
65. Chaudhari NS, Pandey AP, Patil PO, Tekade AR, Bari SB, Deshmukh PK. Graphene oxide based magnetic nanocomposites for efficient treatment of breast cancer. Materials science & engineering C, Materials for biological applications. 2014; 37: 278-85. doi:10.1016/j.msec.2014.01.007.
66. Zhang YM, Cao Y, Yang Y, Chen JT, Liu Y. A small-sized graphene oxide supramolecular assembly for targeted delivery of camptothecin. Chemical communications. 2014; 50: 13066-9. doi:10.1039/c4cc04533e.
67. Kavitha T, Kang IK, Park SY. Poly(N-vinyl caprolactam) grown on nanographene oxide as an effective nanocargo for drug delivery. Colloids and surfaces B, Biointerfaces. 2014; 115: 37-45. doi:10.1016/j.colsurfb.2013.11.022.
68. Maity AR, Chakraborty A, Mondal A, Jana NR. Carbohydrate coated, folate functionalized colloidal graphene as a nanocarrier for both hydrophobic and hydrophilic drugs. Nanoscale. 2014; 6: 2752-8. doi:10.1039/c3nr05431d.
69. Chen H, Wang Z, Zong S, Wu L, Chen P, Zhu D, et al. SERS-fluorescence monitored drug release of a redox-responsive nanocarrier based on graphene oxide in tumor cells. ACS applied materials & interfaces. 2014; 6: 17526-33. doi:10.1021/am505160v.
70. Chen GY, Chen CL, Tuan HY, Yuan PX, Li KC, Yang HJ, et al. Graphene oxide triggers toll-like receptors/autophagy responses in vitro and inhibits tumor growth in vivo. Advanced healthcare materials. 2014; 3: 1486-95. doi:10.1002/adhm.201300591.
71. Joseph D, Seo S, Williams DR, Geckeler KE. Double-stranded DNA-graphene hybrid: preparation and anti-proliferative activity. ACS applied materials & interfaces. 2014; 6: 3347-56. doi:10.1021/am405378x.
72. Chowdhury SM, Surhland C, Sanchez Z, Chaudhary P, Suresh Kumar MA, Lee S, et al. Graphene nanoribbons as a drug delivery agent for lucanthone mediated therapy of glioblastoma multiforme. Nanomedicine. 2014. doi:10.1016/j.nano.2014.08.001.
73. Yang X, Zhao N, Xu FJ. Biocleavable graphene oxide based-nanohybrids synthesized via ATRP for gene/drug delivery. Nanoscale. 2014; 6: 6141-50. doi:10.1039/c4nr00907j.
74. Song E, Han W, Li C, Cheng D, Li L, Liu L, et al. Hyaluronic acid-decorated graphene oxide nanohybrids as nanocarriers for targeted and pH-responsive anticancer drug delivery. ACS applied materials & interfaces. 2014; 6: 11882-90. doi:10.1021/am502423r.
75. Zhao X, Liu L, Li X, Zeng J, Jia X, Liu P. Biocompatible graphene oxide nanoparticle-based drug delivery platform for tumor microenvironment-responsive triggered release of doxorubicin. Langmuir: the ACS journal of surfaces and colloids. 2014; 30: 10419-29. doi:10.1021/la502952f.
76. Xu Z, Wang S, Li Y, Wang M, Shi P, Huang X. Covalent functionalization of graphene oxide with biocompatible poly(ethylene glycol) for delivery of paclitaxel. ACS applied materials & interfaces. 2014; 6: 17268-76. doi:10.1021/am505308f.
77. He D, He X, Wang K, Zou Z, Yang X, Li X. Remote-controlled drug release from graphene oxide-capped mesoporous silica to cancer cells by photoinduced pH-jump activation. Langmuir: the ACS journal of surfaces and colloids. 2014; 30: 7182-9. doi:10.1021/la501075c.
78. Some S, Gwon AR, Hwang E, Bahn GH, Yoon Y, Kim Y, et al. Cancer therapy using ultrahigh hydrophobic drug-loaded graphene derivatives. Scientific reports. 2014; 4: 6314. doi:10.1038/srep06314.
79. Wang C, Chen B, Zou M, Cheng G. Cyclic RGD-modified chitosan/graphene oxide polymers for drug delivery and cellular imaging. Colloids and surfaces B, Biointerfaces. 2014; 122: 332-40. doi:10.1016/j.colsurfb.2014.07.018.
80. Zhou L, Zhou L, Wei S, Ge X, Zhou J, Jiang H, et al. Combination of chemotherapy and photodynamic therapy using graphene oxide as drug delivery system. Journal of photochemistry and photobiology B, Biology. 2014; 135: 7-16. doi:10.1016/j.jphotobiol.2014.04.010.
81. Shi J, Wang L, Zhang J, Ma R, Gao J, Liu Y, et al. A tumor-targeting near-infrared laser-triggered drug delivery system based on GO@Ag nanoparticles for chemo-photothermal therapy and X-ray imaging. Biomaterials. 2014; 35: 5847-61. doi:10.1016/j.biomaterials.2014.03.042.
82. Bai J, Liu Y, Jiang X. Multifunctional PEG-GO/CuS nanocomposites for near-infrared chemo-photothermal therapy. Biomaterials. 2014; 35: 5805-13. doi:10.1016/j.biomaterials.2014.04.008.
83. Wan H, Zhang Y, Liu Z, Xu G, Huang G, Ji Y, et al. Facile fabrication of a near-infrared responsive nanocarrier for spatiotemporally controlled chemo-photothermal synergistic cancer therapy. Nanoscale. 2014; 6: 8743-53. doi:10.1039/c4nr01044b.
84. Bian X, Song ZL, Qian Y, Gao W, Cheng ZQ, Chen L, et al. Fabrication of graphene-isolated-Au-nanocrystal nanostructures for multimodal cell imaging and photothermal-enhanced chemotherapy. Scientific reports. 2014; 4: 6093. doi:10.1038/srep06093.
85. Zhang M, Cao Y, Chong Y, Ma Y, Zhang H, Deng Z, et al. Graphene oxide based theranostic platform for T1-weighted magnetic resonance imaging and drug delivery. ACS applied materials & interfaces. 2013; 5: 13325-32. doi:10.1021/am404292e.
86. Saeed LM, Mahmood M, Pyrek SJ, Fahmi T, Xu Y, Mustafa T, et al. Single-walled carbon nanotube and graphene nanodelivery of gambogic acid increases its cytotoxicity in breast and pancreatic cancer cells. Journal of applied, toxicology: JAT. 2014; 34: 1188-99. doi:10.1002/jat.3018.
87. Wang C, Ravi S, Garapati US, Das M, Howell M, MallelaMallela J, et al. Multifunctional Chitosan Magnetic-Graphene (CMG) Nanoparticles: a Theranostic Platform for Tumor-targeted Co-delivery of Drugs, Genes and MRI Contrast Agents. Journal of materials chemistry B, Materials for biology and medicine. 2013; 1: 4396-405. doi:10.1039/C3TB20452A.
88. Gao Y, Zou X, Zhao JX, Li Y, Su X. Graphene oxide-based magnetic fluorescent hybrids for drug delivery and cellular imaging. Colloids and surfaces B, Biointerfaces. 2013; 112: 128-33. doi:10.1016/j.colsurfb.2013.07.020.
89. Feng L, Yang X, Shi X, Tan X, Peng R, Wang J, et al. Polyethylene glycol and polyethylenimine dual-functionalized nano-graphene oxide for photothermally enhanced gene delivery. Small. 2013; 9: 1989-97. doi:10.1002/smll.201202538.
90. Wang Y, Huang R, Liang G, Zhang Z, Zhang P, Yu S, et al. MRI-visualized, dual-targeting, combined tumor therapy using magnetic graphene-based mesoporous silica. Small. 2014; 10: 109-16. doi:10.1002/smll.201301297.
91. Chen GY, Meng CL, Lin KC, Tuan HY, Yang HJ, Chen CL, et al. Graphene oxide as a chemosensitizer: Diverted autophagic flux, enhanced nuclear import, elevated necrosis and improved antitumor effects. Biomaterials. 2015; 40: 12-22. doi:10.1016/j.biomaterials.2014.11.034.
92. Feng L, Li K, Shi X, Gao M, Liu J, Liu Z. Smart pH-responsive nanocarriers based on nano-graphene oxide for combined chemo- and photothermal therapy overcoming drug resistance. Advanced healthcare materials. 2014; 3: 1261-71. doi:10.1002/adhm.201300549.
93. Tomei S, Wang E, Delogu LG, Marincola FM, Bedognetti D. Non-BRAF-targeted therapy, immunotherapy, and combination therapy for melanoma. Expert opinion on biological therapy. 2014; 14: 663-86. doi:10.1517/14712598.2014.890586.
94. Bedognetti D, Spivey TL, Zhao Y, Uccellini L, Tomei S, Dudley ME, et al. CXCR3/CCR5 pathways in metastatic melanoma patients treated with adoptive therapy and interleukin-2. British journal of cancer. 2013; 109: 2412-23. doi:10.1038/bjc.2013.557.
95. Robinson JT, Tabakman SM, Liang Y, Wang H, Casalongue HS, Vinh D, et al. Ultrasmall reduced graphene oxide with high near-infrared absorbance for photothermal therapy. Journal of the American Chemical Society. 2011; 133: 6825-31. doi:10.1021/ja2010175.
96. Hu SH, Chen YW, Hung WT, Chen IW, Chen SY. Quantum-dot-tagged reduced graphene oxide nanocomposites for bright fluorescence bioimaging and photothermal therapy monitored in situ. Advanced materials. 2012; 24: 1748-54. doi:10.1002/adma.201104070.
97. Yang K, Hu L, Ma X, Ye S, Cheng L, Shi X, et al. Multimodal imaging guided photothermal therapy using functionalized graphene nanosheets anchored with magnetic nanoparticles. Advanced materials. 2012; 24: 1868-72. doi:10.1002/adma.201104964.
98. Yang K, Wan J, Zhang S, Tian B, Zhang Y, Liu Z. The influence of surface chemistry and size of nanoscale graphene oxide on photothermal therapy of cancer using ultra-low laser power. Biomaterials. 2012; 33: 2206-14. doi:10.1016/j.biomaterials.2011.11.064.
99. Abdolahad M, Janmaleki M, Mohajerzadeh S, Akhavan O, Abbasi S. Polyphenols attached graphene nanosheets for high efficiency NIR mediated photodestruction of cancer cells. Materials science & engineering C, Materials for biological applications. 2013; 33: 1498-505. doi:10.1016/j.msec.2012.12.052.
100. Sheng Z, Song L, Zheng J, Hu D, He M, Zheng M, et al. Protein-assisted fabrication of nano-reduced graphene oxide for combined in vivo photoacoustic imaging and photothermal therapy. Biomaterials. 2013; 34: 5236-43. doi:10.1016/j.biomaterials.2013.03.090.
101. Jin Y, Wang J, Ke H, Wang S, Dai Z. Graphene oxide modified PLA microcapsules containing gold nanoparticles for ultrasonic/CT bimodal imaging guided photothermal tumor therapy. Biomaterials. 2013; 34: 4794-802. doi:10.1016/j.biomaterials.2013.03.027.
102. Wang Y, Wang H, Liu D, Song S, Wang X, Zhang H. Graphene oxide covalently grafted upconversion nanoparticles for combined NIR mediated imaging and photothermal/photodynamic cancer therapy. Biomaterials. 2013; 34: 7715-24. doi:10.1016/j.biomaterials.2013.06.045.
103. Sahu A, Choi WI, Lee JH, Tae G. Graphene oxide mediated delivery of methylene blue for combined photodynamic and photothermal therapy. Biomaterials. 2013; 34: 6239-48. doi:10.1016/j.biomaterials.2013.04.066.
104. Hou C, Quan H, Duan Y, Zhang Q, Wang H, Li Y. Facile synthesis of water-dispersible Cu2O nanocrystal-reduced graphene oxide hybrid as a promising cancer therapeutic agent. Nanoscale. 2013; 5: 1227-32. doi:10.1039/c2nr32938g.
105. Shi X, Gong H, Li Y, Wang C, Cheng L, Liu Z. Graphene-based magnetic plasmonic nanocomposite for dual bioimaging and photothermal therapy. Biomaterials. 2013; 34: 4786-93. doi:10.1016/j.biomaterials.2013.03.023.
106. Gollavelli G, Ling YC. Magnetic and fluorescent graphene for dual modal imaging and single light induced photothermal and photodynamic therapy of cancer cells. Biomaterials. 2014; 35: 4499-507. doi:10.1016/j.biomaterials.2014.02.011.
107. Nergiz SZ, Gandra N, Tadepalli S, Singamaneni S. Multifunctional hybrid nanopatches of graphene oxide and gold nanostars for ultraefficient photothermal cancer therapy. ACS applied materials & interfaces. 2014; 6: 16395-402. doi:10.1021/am504795d.
108. Dembereldorj U, Choi SY, Ganbold EO, Song NW, Kim D, Choo J, et al. Gold nanorod-assembled PEGylated graphene-oxide nanocomposites for photothermal cancer therapy. Photochemistry and photobiology. 2014; 90: 659-66. doi:10.1111/php.12212.
109. Li JL, Hou XL, Bao HC, Sun L, Tang B, Wang JF, et al. Graphene oxide nanoparticles for enhanced photothermal cancer cell therapy under the irradiation of a femtosecond laser beam. Journal of biomedical materials research Part A. 2014; 102: 2181-8. doi:10.1002/jbm.a.34871.
110. Rong P, Yang K, Srivastan A, Kiesewetter DO, Yue X, Wang F, et al. Photosensitizer loaded nano-graphene for multimodality imaging guided tumor photodynamic therapy. Theranostics. 2014; 4: 229-39. doi:10.7150/thno.8070.
111. Wate PS, Banerjee SS, Jalota-Badhwar A, Mascarenhas RR, Zope KR, Khandare J, et al. Cellular imaging using biocompatible dendrimer-functionalized graphene oxide-based fluorescent probe anchored with magnetic nanoparticles. Nanotechnology. 2012; 23: 415101. doi:10.1088/0957-4484/23/41/415101.
112. Splinter R, and Brett A. Hooper. An introduction to biomedical optics. CRC Press; 2006.
113. Hirsch LR, Stafford RJ, Bankson JA, Sershen SR, Rivera B, Price RE, et al. Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proceedings of the National Academy of Sciences of the United States of America. 2003; 100: 13549-54. doi:10.1073/pnas.2232479100.
114. von Maltzahn G, Park JH, Agrawal A, Bandaru NK, Das SK, Sailor MJ, et al. Computationally guided photothermal tumor therapy using long-circulating gold nanorod antennas. Cancer research. 2009; 69: 3892-900. doi:10.1158/0008-5472.CAN-08-4242.
115. Hasan W, Stender CL, Lee MH, Nehl CL, Lee J. Tailoring the structure of nanopyramids for optimal heat generation. Nano letters. 2009; 9: 1555-8. doi:10.1021/nl803647n.
116. Ghosh S, Dutta S, Gomes E, Carroll D, D'Agostino R, Jr., Olson J, et al. Increased heating efficiency and selective thermal ablation of malignant tissue with DNA-encased multiwalled carbon nanotubes. ACS nano. 2009; 3: 2667-73. doi:10.1021/nn900368b.
117. Wang S, Zhang Q, Luo XF, Li J, He H, Yang F, et al. Magnetic graphene-based nanotheranostic agent for dual-modality mapping guided photothermal therapy in regional lymph nodal metastasis of pancreatic cancer. Biomaterials. 2014; 35: 9473-83. doi:10.1016/j.biomaterials.2014.07.064.
118. Zhou T, Zhang B, Wei P, Du Y, Zhou H, Yu M, et al. Energy metabolism analysis reveals the mechanism of inhibition of breast cancer cell metastasis by PEG-modified graphene oxide nanosheets. Biomaterials. 2014; 35: 9833-43. doi:10.1016/j.biomaterials.2014.08.033.
119. Huang P, Xu C, Lin J, Wang C, Wang X, Zhang C, et al. Folic Acid-conjugated Graphene Oxide loaded with Photosensitizers for Targeting Photodynamic Therapy. Theranostics. 2011; 1: 240-50.
120. Josefsen LB, Boyle RW. Unique diagnostic and therapeutic roles of porphyrins and phthalocyanines in photodynamic therapy, imaging and theranostics. Theranostics. 2012; 2: 916-66. doi:10.7150/thno.4571.
121. Ge J, Lan M, Zhou B, Liu W, Guo L, Wang H, et al. A graphene quantum dot photodynamic therapy agent with high singlet oxygen generation. Nature communications. 2014; 5: 4596. doi:10.1038/ncomms5596.
122. Hu Z, Huang YD, Sun SF, Guan WC, Yao YH, Tang PY, et al. Visible light driven photodynamic anticancer activity of graphene oxide/TiO2 hybrid. Carbon. 2012; 50: 994-1004. doi:Doi 10.1016/J. Carbon.2011.10.002.
123. Khdair A, Gerard B, Handa H, Mao G, Shekhar MP, Panyam J. Surfactant-polymer nanoparticles enhance the effectiveness of anticancer photodynamic therapy. Molecular pharmaceutics. 2008; 5: 795-807. doi:10.1021/mp800026t.
124. Austin M. Derfus WCWCaSNB. Probing the Cytotoxicity of Semiconductor Quantum Dots. Nano letters. 2004; 4.
125. Li JL, Tang B, Yuan B, Sun L, Wang XG. A review of optical imaging and therapy using nanosized graphene and graphene oxide. Biomaterials. 2013; 34: 9519-34. doi:10.1016/j.biomaterials.2013.08.066.
126. Cornelissen B, Able S, Kersemans V, Waghorn PA, Myhra S, Jurkshat K, et al. Nanographene oxide-based radioimmunoconstructs for in vivo targeting and SPECT imaging of HER2-positive tumors. Biomaterials. 2013; 34: 1146-54. doi:10.1016/j.biomaterials.2012.10.054.
127. Yang HW, Huang CY, Lin CW, Liu HL, Huang CW, Liao SS, et al. Gadolinium-functionalized nanographene oxide for combined drug and microRNA delivery and magnetic resonance imaging. Biomaterials. 2014; 35: 6534-42. doi:10.1016/j.biomaterials.2014.04.057.
128. Zhang LN, Deng HH, Lin FL, Xu XW, Weng SH, Liu AL, et al. In situ growth of porous platinum nanoparticles on graphene oxide for colorimetric detection of cancer cells. Analytical chemistry. 2014; 86: 2711-8. doi:10.1021/ac404104j.
129. Bianying F, Linjie G, Lihua W, Fan L, Jianxin L, Jimin G, et al. A graphene oxide-based fluorescent biosensor for the analysis of peptide-receptor interactions and imaging in somatostatin receptor subtype 2 overexpressed tumor cells. Analytical chemistry. 2013; 85: 7732-7. doi:10.1021/ac4009463.
130. Delogu LG, Venturelli E, Manetti R, Pinna GA, Carru C, Madeddu R, et al. Ex vivo impact of functionalized carbon nanotubes on human immune cells. Nanomedicine. 2012; 7: 231-43. doi:10.2217/nnm.11.101.
131. Pescatori M, Bedognetti D, Venturelli E, Menard-Moyon C, Bernardini C, Muresu E, et al. Functionalized carbon nanotubes as immunomodulator systems. Biomaterials. 2013; 34: 4395-403. doi:10.1016/j.biomaterials.2013.02.052.
132. Crescio C, Orecchioni M, Menard-Moyon C, Sgarrella F, Pippia P, Manetti R, et al. Immunomodulatory properties of carbon nanotubes are able to compensate immune function dysregulation caused by microgravity conditions. Nanoscale. 2014; 6: 9599-603. doi:10.1039/c4nr02711f.
133. Sasidharan A, Panchakarla LS, Chandran P, Menon D, Nair S, Rao CN, et al. Differential nano-bio interactions and toxicity effects of pristine versus functionalized graphene. Nanoscale. 2011; 3: 2461-4. doi:10.1039/c1nr10172b.
134. Vallabani NV, Mittal S, Shukla RK, Pandey AK, Dhakate SR, Pasricha R, et al. Toxicity of graphene in normal human lung cells (BEAS-2B). Journal of biomedical nanotechnology. 2011; 7: 106-7.